Former BioMimetic Therapeutics executives at center of new initiatives.
Two Tennessee-born science-centered companies are united
Corporate ambitions may suggest a role for outside capital in this high-profile local growth company
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: